Neuroendocrine Tumors Therapeutics Market Size, Share Analysis 2024

added article Health

2024-02-07 12:35:32 -

The report "Neuroendocrine Tumors Therapeutics Market by Drug Class (Somatostatin Analogues,(Octreotide, Lanreotide, Pasireotide), Chemotherapeutics (Fluorouracil (5-FU), Doxorubicin (Adriamycin) or liposomal doxorubicin (Doxil), Streptozocin, Temozolomide (Temodar), Capecitabine (Xeloda), Dacarbazine (DTIC), Oxaliplatin (Eloxatin)), Targeted Therapeutics, (Sunitinib, Everolimus, Others)),...

0 Comments 0 Shares 1104 Views 0 Reviews